Aerovate Therapeutics Organization
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Connections from
Industry:
PharmTech
Last Funding Type:
Series A
Funding Status:
IPO
Total Funding:
72600000
Headquarters:
Boston, Massachusetts, United States
Technology:
Anti-infective Drugs
Investor Type:
Healthcare Company
Founded Date:
2019
Employee Number:
1-10